DK2490D0 - Rekombinante fibroblastvaekstfaktorer - Google Patents
Rekombinante fibroblastvaekstfaktorerInfo
- Publication number
- DK2490D0 DK2490D0 DK002490A DK2490A DK2490D0 DK 2490 D0 DK2490 D0 DK 2490D0 DK 002490 A DK002490 A DK 002490A DK 2490 A DK2490 A DK 2490A DK 2490 D0 DK2490 D0 DK 2490D0
- Authority
- DK
- Denmark
- Prior art keywords
- growth factors
- fibroblast growth
- recombinant fibroblast
- recombinant
- factors
- Prior art date
Links
- 102000018233 Fibroblast Growth Factor Human genes 0.000 title 1
- 108050007372 Fibroblast Growth Factor Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/50—Fibroblast growth factor [FGF]
- C07K14/501—Fibroblast growth factor [FGF] acidic FGF [aFGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/50—Fibroblast growth factor [FGF]
- C07K14/503—Fibroblast growth factor [FGF] basic FGF [bFGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/001—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
- C12N2830/002—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination inducible enhancer/promoter combination, e.g. hypoxia, iron, transcription factor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/15—Vector systems having a special element relevant for transcription chimeric enhancer/promoter combination
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/55—Vector systems having a special element relevant for transcription from bacteria
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/80—Vector systems having a special element relevant for transcription from vertebrates
- C12N2830/85—Vector systems having a special element relevant for transcription from vertebrates mammalian
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Molecular Biology (AREA)
- Public Health (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Toxicology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Gastroenterology & Hepatology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Hospice & Palliative Care (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Psychiatry (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US7079787A | 1987-07-07 | 1987-07-07 | |
PCT/US1988/002264 WO1989000198A1 (en) | 1987-07-07 | 1988-07-06 | Recombinant fibroblast growth factors |
Publications (2)
Publication Number | Publication Date |
---|---|
DK2490D0 true DK2490D0 (da) | 1990-01-05 |
DK2490A DK2490A (da) | 1990-03-06 |
Family
ID=22097443
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK002490A DK2490A (da) | 1987-07-07 | 1990-01-05 | Rekombinante fibroblastvaekstfaktorer |
Country Status (7)
Country | Link |
---|---|
EP (2) | EP0377579A1 (da) |
JP (4) | JP2879148B2 (da) |
AU (1) | AU629176B2 (da) |
CA (1) | CA1341639C (da) |
DK (1) | DK2490A (da) |
IL (1) | IL87025A (da) |
WO (1) | WO1989000198A1 (da) |
Families Citing this family (48)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5852177A (en) * | 1987-02-24 | 1998-12-22 | Takeda Chemical Industries, Ltd. | Basic fibroblast growth factor (bFGF) muteins |
JP2526965B2 (ja) * | 1987-02-24 | 1996-08-21 | 武田薬品工業株式会社 | ムテイン,dnaおよびその用途 |
US5312911A (en) * | 1987-10-22 | 1994-05-17 | Merck & Co., Inc. | Cysteine-modified acidic fibroblast growth factor |
US5223483A (en) * | 1987-10-22 | 1993-06-29 | Merck & Co., Inc. | Cysteine-modified acidic fibroblast growth factor |
US5814602A (en) * | 1988-03-17 | 1998-09-29 | Novo Nordisk A/S | Heparin-binding proteins |
IL89661A (en) * | 1988-03-17 | 1999-05-09 | Novo Nordisk As | Heparin binding proteins |
GB2223496B (en) * | 1988-08-08 | 1992-05-27 | British Bio Technology | Synthetic gene encoding mature human acid fibroblast growth factor |
GB2223495B (en) * | 1988-08-08 | 1992-05-20 | British Bio Technology | Synthetic gene encoding basic fibroblast growth factor |
GB2223497B (en) * | 1988-08-08 | 1992-04-01 | British Bio Technology | Synthetic gene encoding human beta endothelial cell growth factor |
US5175147A (en) * | 1988-08-19 | 1992-12-29 | Takeda Chemical Industries, Ltd | Acid-resistant fgf composition and method of treating ulcerating diseases of the gastrointestinal tract |
GB8821795D0 (en) * | 1988-09-16 | 1988-10-19 | Erba Carlo Spa | New derivatives of human/bovine basic fibroplast growth factor |
FR2642086B1 (fr) * | 1989-01-26 | 1992-09-04 | Sanofi Sa | Gene recombinant codant pour un facteur basique de croissance des fibroblastes et ledit facteur |
US7238673B2 (en) | 1989-03-31 | 2007-07-03 | The Regents Of The University Of Michigan | Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor |
CA2015313A1 (en) * | 1989-04-26 | 1990-10-26 | Masaharu Senoo | Glycosylated fgf and production thereof |
US5464943A (en) * | 1989-04-26 | 1995-11-07 | Takeda Chemical Industries, Ltd. | DNA encoding glycosylated FGF and production thereof |
JPH0343088A (ja) * | 1989-09-29 | 1991-02-25 | Takeda Chem Ind Ltd | aFGF蛋白質の製造法 |
EP0406738A3 (en) * | 1989-07-03 | 1991-08-14 | Takeda Chemical Industries, Ltd. | Production of acidic fgf protein |
EP0420222A1 (en) * | 1989-09-29 | 1991-04-03 | Takeda Chemical Industries, Ltd. | Mutein of acidic FGF, and its production |
JPH047617A (ja) * | 1990-04-26 | 1992-01-13 | Canon Inc | 電子機器 |
US5612211A (en) * | 1990-06-08 | 1997-03-18 | New York University | Stimulation, production and culturing of hematopoietic progenitor cells by fibroblast growth factors |
JPH05509096A (ja) * | 1990-06-08 | 1993-12-16 | ニューヨークユニバーシティ | 骨髄間質細胞及び始原細胞の刺激 |
US5310883A (en) * | 1990-11-23 | 1994-05-10 | American Cyanamid Company | Chimeric fibroblast growth factors |
US5206354A (en) * | 1990-11-23 | 1993-04-27 | American Cyanamid Company | Dna sequence encoding active fragment of fibroblast growth factor, hbf-2 |
CA2098484A1 (en) * | 1990-12-18 | 1992-06-19 | Tsutomu Arakawa | Analogs of acidic fibroblast growth factor having enhanced stability and biological activity |
GR1002610B (el) * | 1991-01-02 | 1997-02-20 | Johnson & Johnson Consumer Products Inc. | Θεραπευτικες συνθεσεις πληγων που περιεχουν παραγοντα αναπτυξης ινοβλαστων και ασκορβικον οξυ. |
EP0499242B1 (en) * | 1991-02-15 | 1996-06-26 | Takeda Chemical Industries, Ltd. | Stimulation of endosteal bone formation with a cell growth factor |
US5192312A (en) * | 1991-03-05 | 1993-03-09 | Colorado State University Research Foundation | Treated tissue for implantation and methods of treatment and use |
US5492894A (en) * | 1991-03-21 | 1996-02-20 | The Procter & Gamble Company | Compositions for treating wrinkles comprising a peptide |
JP3303211B2 (ja) * | 1991-04-26 | 2002-07-15 | 武田薬品工業株式会社 | bFGFムテインおよびその製造法 |
JPH07504160A (ja) * | 1991-11-27 | 1995-05-11 | インスティチュート オブ モレキュラー バイオロジー インク | 骨の再生 |
US5461029A (en) * | 1992-04-24 | 1995-10-24 | American Cyanamid Company | Method of treating herpes viral infections using HBNF and MK proteins |
US5965530A (en) * | 1993-03-26 | 1999-10-12 | Amgen Inc. | Therapeutic uses of keratinocyte growth factor |
TW275068B (da) * | 1993-09-24 | 1996-05-01 | American Cyanamid Co | |
EP1452153A1 (en) * | 1994-03-14 | 2004-09-01 | Cryolife, Inc | Treated tissue for implantation and preparation methods |
WO1996039420A1 (en) * | 1995-06-05 | 1996-12-12 | Human Genome Sciences, Inc. | Human criptin growth factor |
US6743422B1 (en) | 1996-10-15 | 2004-06-01 | Amgen, Inc. | Keratinocyte growth factor-2 products |
US6214795B1 (en) * | 1996-11-12 | 2001-04-10 | Praecis Pharmaceuticals, Inc. | Peptide compounds useful for modulating FGF receptor activity |
AU3170499A (en) * | 1998-04-28 | 1999-11-16 | Eisai Co. Ltd. | Fibroblast growth factor mutein compositions and methods of use therefor |
US7252818B2 (en) | 1998-07-24 | 2007-08-07 | Cardiovascular Biotherapeutics, Inc. | Method of producing biologically active human acidic fibroblast growth factor and its use in promoting angiogenesis |
US6642026B2 (en) | 2000-08-15 | 2003-11-04 | Phage Biotechnology Corporation | Method of producing biologically active human acidic fibroblast growth factor and its use in promoting angiogenesis |
WO2001049740A1 (en) * | 2000-01-05 | 2001-07-12 | Zymogenetics, Inc. | Novel fgf homolog zfgf12 |
WO2001049849A1 (en) * | 2000-01-05 | 2001-07-12 | Zymogenetics, Inc. | Novel fgf homolog zfgf11 |
US8440295B2 (en) | 2005-04-22 | 2013-05-14 | Eagle Industry Co. Ltd. | Mechanical seal device, sliding element, and method of production thereof |
US7816140B2 (en) | 2005-06-14 | 2010-10-19 | The United States Of America As Represented By The Department Of Veterans Affairs | Composition and methods for osteogenic gene therapy |
US8772460B2 (en) * | 2011-12-16 | 2014-07-08 | Wisconsin Alumni Research Foundation | Thermostable FGF-2 mutant having enhanced stability |
CN103882028B (zh) * | 2014-03-18 | 2016-08-31 | 杨霞 | 重组人碱性成纤维细胞生长因子蛋白的制备方法 |
WO2021107473A1 (ko) * | 2019-11-25 | 2021-06-03 | 한국해양과학기술원 | 온도안정성 및 단백질 분해효소 저항성을 향상시킨 fgf2 폴리펩타이드 및 그 용도 |
CN117486996B (zh) * | 2023-12-21 | 2024-03-19 | 朗肽生物制药股份有限公司 | 一种改构的重组人酸性成纤维细胞生长因子的制备及其在皮肤修复中的应用 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FI82266C (fi) * | 1982-10-19 | 1991-02-11 | Cetus Corp | Foerfarande foer framstaellning av il-2 -mutein. |
US4956455A (en) * | 1984-03-05 | 1990-09-11 | The Salk Institute For Biological Studies | Bovine fibroblast growth factor |
US4868113A (en) * | 1986-03-03 | 1989-09-19 | Rorer Biotechnology, Inc. | Recombinant DNA vector encoding human endothelial cell growth factor |
-
1988
- 1988-07-06 EP EP88906510A patent/EP0377579A1/en active Pending
- 1988-07-06 AU AU20846/88A patent/AU629176B2/en not_active Ceased
- 1988-07-06 JP JP63506136A patent/JP2879148B2/ja not_active Expired - Lifetime
- 1988-07-06 EP EP88306158A patent/EP0298723A1/en not_active Ceased
- 1988-07-06 WO PCT/US1988/002264 patent/WO1989000198A1/en not_active Application Discontinuation
- 1988-07-07 CA CA571439A patent/CA1341639C/en active Active
- 1988-07-07 IL IL87025A patent/IL87025A/xx unknown
-
1990
- 1990-01-05 DK DK002490A patent/DK2490A/da not_active Application Discontinuation
-
1998
- 1998-08-10 JP JP10226371A patent/JP2953573B2/ja not_active Expired - Lifetime
- 1998-08-10 JP JP10226376A patent/JP2953574B2/ja not_active Expired - Lifetime
- 1998-08-10 JP JP10226370A patent/JPH11103874A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
JP2953573B2 (ja) | 1999-09-27 |
JPH11103876A (ja) | 1999-04-20 |
IL87025A0 (en) | 1988-12-30 |
AU2084688A (en) | 1989-01-30 |
JPH11103875A (ja) | 1999-04-20 |
JP2879148B2 (ja) | 1999-04-05 |
CA1341639C (en) | 2014-07-08 |
JPH11103874A (ja) | 1999-04-20 |
IL87025A (en) | 1993-05-13 |
WO1989000198A1 (en) | 1989-01-12 |
JP2953574B2 (ja) | 1999-09-27 |
EP0377579A1 (en) | 1990-07-18 |
AU629176B2 (en) | 1992-10-01 |
DK2490A (da) | 1990-03-06 |
JPH03504916A (ja) | 1991-10-31 |
EP0298723A1 (en) | 1989-01-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK2490D0 (da) | Rekombinante fibroblastvaekstfaktorer | |
DE3890874C5 (de) | Rekombinante Viren | |
DK603888A (da) | Rekombinant virus | |
DK97790A (da) | Renin-inhiberende peptider | |
YU163289A (en) | Recombinant animal somatotropine | |
FI892714A0 (fi) | Rekombinant-coccidiosisvaccin. | |
DK580888D0 (da) | Mejetaersker | |
DK353788D0 (da) | Polypeptidderivater | |
DK354389D0 (da) | Polypeptid | |
NO169173C (no) | Veksthormon-frigjoerende peptider | |
KR960016703B1 (en) | Recombinant avipoxvirus | |
FI895456A0 (fi) | Rekombinant interleukin 2-hybridproteiner. | |
DK492588A (da) | Merozoit-antigen polypeptider | |
DK555488D0 (da) | Sekretionssignal | |
DK472189D0 (da) | Vaeksthormon | |
DK652788D0 (da) | Glycoprotein | |
PT86162A (en) | Recombinant protein expression | |
DK596888D0 (da) | Rekombinant lymfotoksin | |
IE882056L (en) | Recombinant fibroblast growth factors | |
ZA908042B (en) | Recombinant growth factors | |
DK624089D0 (da) | Polypeptidforbindelser | |
KR890006141U (ko) | 신변장신구 | |
BR6701997U (pt) | Toalha de mesa | |
DE3687042D1 (de) | Peptidanalogedes insulinaehnlichen wachstumsfaktors-1 bei saeugetieren. | |
DK136088D0 (da) | Peptid |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AHB | Application shelved due to non-payment |